The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALECTOR INC COM 014442107 22,384 980,894 SH   SOLE   980,894 0 0
FIRST FINL BANCORP OH COM 320209109 4,063 173,576 SH   SOLE   173,576 0 0
FOGHORN THERAPEUTICS INC COM 344174107 17,569 1,261,261 SH   SOLE   1,261,261 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 17,494 832,274 SH   SOLE   832,274 0 0
ORIC PHARMACEUTICALS INC COM 68622P109 16,251 777,193 SH   SOLE   777,193 0 0
PINDUODUO INC SPONSORED ADS 722304102 1,112 12,262 SH   SOLE   12,262 0 0
PMV PHARMACEUTICALS INC COM 69353Y103 82,540 2,769,813 SH   SOLE   2,769,813 0 0
RAPT THERAPEUTICS INC COM 75382E109 19,722 635,177 SH   SOLE   635,177 0 0
SURROZEN INC COM 86889P109 5,685 802,965 SH   SOLE   802,965 0 0
TENAYA THERAPEUTICS INC COM 87990A106 18,909 915,705 SH   SOLE   915,705 0 0